http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Flex Pharma Reports Third Quarter 2016 Financial Results
-
Flex Pharma to Report Third Quarter 2016 Results on November 2, 2016
-
Flex Pharma Presenting at Upcoming Investor Conferences in September 2016
-
Flex Pharma Announces Scientific Advisory Board Appointment and Management Change
-
Flex Pharma Reports Second Quarter 2016 Financial Results
-
Flex Pharma to Report Second Quarter 2016 Results on August 3, 2016
-
Flex Pharma Completes Enrollment of Human Proof-of Concept Efficacy Study in Nocturnal Leg Cramps
-
Flex Pharma to Present at the Cantor Fitzgerald Healthcare Conference
-
Flex Pharma Presenting at Upcoming Investor Conferences in June 2016
-
Scientific Breakthrough In Sports Nutrition To Change The Game For Millions Of Endurance Athletes
-
Flex Pharma Launches First Consumer Product Scientifically Proven to Prevent and Treat Muscle Cramps
-
Flex Pharma Reports First Quarter 2016 Financial Results
-
Flex Pharma to Report First Quarter 2016 Results on May 4, 2016
-
Flex Pharma Reports Year End 2015 Financial Results
-
Michelle V. Stacy Joins Flex Pharma’s Board of Directors
-
Flex Pharma to Report Full Year 2015 Results on March 8, 2016
-
Flex Pharma Presents at the 26th International Symposium on ALS/MND
-
Flex Pharma Presenting at Two Upcoming Healthcare Investor Conferences in December 2015
-
Flex Pharma Presenting at Two Upcoming Healthcare Investor Conferences in November 2015
-
Flex Pharma Announces FLX-787 as Clinical Drug Candidate
-
Flex Pharma Reports Third Quarter 2015 Financial Results
-
Flex Pharma Demonstrates Single Agent Efficacy and Dose Response in Reducing Human Muscle Cramps
-
Flex Pharma Co-Founder and Harvard Medical School Professor Bruce Bean to Speak about Chemical Neuro Stimulation at Neuro Advance Boston
-
Flex Pharma Partners with Five Time World Champion Triathlete Craig “Crowie” Alexander
-
Flex Pharma Demonstrates Efficacy of Synthesized Single and Combination Agents in Reducing Human Muscle Cramps
-
Flex Pharma to Present at the Ladenburg Thalmann Investment Conference
-
Flex Pharma Educates Athletes about Breakthrough Discovery
-
Flex Pharma Appoints Kathie Lindemann Chief Operating Officer
-
Rob Perez Joins Flex Pharma’s Board of Directors
-
Flex Pharma to Present at the Rodman & Renshaw Investment Conference
-
Flex Pharma Reports Second Quarter 2015 Financial Results
-
Flex Pharma Announces Reduction of Muscle Cramping in Athletes
-
Flex Pharma to Present at the Cantor Fitzgerald Inaugural Healthcare Conference
-
Alfred Sandrock, Jr., M.D., Ph.D., Chief Medical Officer of Biogen, Joins Flex Pharma’s Scientific Advisory Board
-
Flex Pharma Presenting at Two Upcoming Consumer Investor Conferences in June 2015
-
Flex Pharma, Inc. (Nasdaq: FLKS) to Ring The Nasdaq Stock Market Closing Bell
-
Flex Pharma, Inc. (Nasdaq: FLKS) to Ring The Nasdaq Stock Market Closing Bell